1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Advanced Primary Peritoneal High Grade Serous Adenocarcinoma: new trials by email Literature Review of Advanced Primary Peritoneal High Grade Serous Adenocarcinoma trials Research Report on Advanced Primary Peritoneal High Grade Serous Adenocarcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial Biopsy, Biospecimen Collection, Computed Tomography - Advanced Fallopian Tube Carcinoma, Advanced Fallopian Tube High Grade Serous Adenocarcinoma | Phase 2 | Recruiting | Mayo Clinic | 78 | 2024-11-12 | 2026-10-02 |
Biopsy (1) · Diphtheria Toxoid (1) · Diphtheria-Tetanus Vaccine (1) · Diphtheria-Tetanus-acellular Pertussis Vaccines (1) · Leukapheresis (1) · Magnetic Resonance Spectroscopy (1) · Specimen Handling (1) · Tetanus Toxoid (1) · adacel (1)
Mayo Clinic (1)
United States (1)